Biomia
PrivateLast Round
Accelerator
Feb 9, 2026
Total Funding Raised
$15.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biomia is a synthetic biology company that engineers and develops nature-inspired small molecule therapeutics to treat central nervous system (CNS) disorders such as pain, addiction, and depression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomia Comparables
Compare Biomia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myria Biosciences | 89% | |
| Generare | 79% | |
| Forecast Bio, Inc. | 73% |
Biomia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 9, 2026 | ||||
| Pre Seed | Sep 26, 2023 | ||||
| Grant | Jan 1, 2019 |
Key People
Founding team and executive leadership
Biomia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nucleus Capital | Pre Seed |
| Novo Nordisk Foundation | Pre Seed |
| Amino Collective | Pre Seed |
| One Mind | Accelerator |
| European Union | Grant, Pre Seed |
| BioInnovation Institute | Pre Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2026
Secured funding from One Mind.
- Jul 3, 2025
Monthly visitors increased 124% MoM.
Biomia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biomia's valuation, stock price, and market status.
Is Biomia a public or private company?
Biomia is a private company.
What is the current stock price of Biomia?
Biomia is a private company with no public stock price. No recent secondary market data is available.
How much is Biomia worth (valuation)?
Valuation information for Biomia is not publicly available.
Can I buy Biomia stock?
Biomia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biomia's last funding round?
Biomia's most recent funding round was Accelerator on February 9, 2026.
Who are the main investors in Biomia?
Key investors in Biomia include Nucleus Capital, Novo Nordisk Foundation, Amino Collective, One Mind, European Union.
Will Biomia IPO soon?
No public IPO plans have been announced for Biomia.
How can I track Biomia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomia's secondary market activity and sign up for updates.